NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $424,000 | +731.4% | 25,587 | +1046.4% | 0.00% | +300.0% |
| Q2 2020 | $51,000 | -23.9% | 2,232 | -50.4% | 0.00% | 0.0% |
| Q4 2014 | $67,000 | +15.5% | 4,501 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $58,000 | – | 4,501 | +37408.3% | 0.00% | – |
| Q2 2014 | $0 | – | 12 | +1100.0% | 0.00% | – |
| Q1 2014 | $0 | -100.0% | 1 | -98.1% | 0.00% | – |
| Q3 2013 | $3,000 | -97.4% | 52 | -99.4% | 0.00% | -100.0% |
| Q2 2013 | $116,000 | – | 8,899 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |